Detailed price information for Generac Holdings Inc (GNRC-N) from The Globe and Mail including charting and trades.

GNRC is set to report Q4 results as revenues and earnings are expected to fall amid weak residential demand and shifting sales mix.

The storm has left 933,000 homes and businesses without electricity from Texas through the Mid-South and East Coast, as ice and heavy snow down power lines and force grid operators to tap emergency ...

Shares of Generac have been trading unevenly as investors balance growing concern around grid reliability and extreme weather against the company's exposure to housing-linked cyclicality. The current ...

ChatGPT thinks Generac stock could trade higher over the next 60 days, projecting an average price around $180.50 by mid-April. Investors looking to express a view can build exposure incrementally ...

Aaron Jagdfeld, CEO of Generac, joins 'Money Movers' to discuss the impacts of winter weather, tariffs, and more. Got a confidential news tip? We want to hear from you. Sign up for free newsletters ...

Weather, supply, tariffs, labor and changing consumer habits continue to drive up the cost of groceries. President Trump falsely claims prices are falling. By Kevin Draper and Julie Creswell Days away ...

I’LL HAVE DETAILS ON HOW LONG IT STAYS LIKE THIS. ALL COMING UP. ALL RIGHT. LINDSAY. THANK YOU. WITH COLD TEMPERATURES ON THE WAY, GENERAC IS HELPING THOSE WHO ARE LESS FORTUNATE STAY WARM THIS WINTER ...

The biggest increase in wholesale prices in three and a half years stunned Wall Street, but is tariff-related inflation really set to soar? The proof is far from ironclad. The latest pair of inflation ...

Power generation stock Generac Holdings Inc (NYSE:GNRC) was last seen up 4.8% at $148.64, after an upgrade from Citigroup to "buy" from "neutral." The firm noted attractive valuation after the stock's ...

Share on Pinterest U.S. drug manufacturers are expected to raise prices on at least 350 prescription medications. Anna Moneymaker/Getty Images A new report states that U.S. drugmakers will increase ...